Skip to content
10-Q

Quarterly Report

Orthofix Medical Inc. OFIX

0000950170-25-102384

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 39.49M sh
Shares Diluted Q2 2025 · Jun 30, 2025 39.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 39.32M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 38.02M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 37.79M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$6.75M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$9.61M
Long Term Debt Q2 2025 · Jun 30, 2025 $157.05M
Long Term Debt Q2 2025 · Dec 31, 2024 $157.02M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $65.61M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $83.24M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $26.37M
Stockholders Equity Q2 2025 · Jun 30, 2025 $458.35M
Stockholders Equity Q2 2025 · Mar 31, 2025 $458.29M
Stockholders Equity Q2 2025 · Dec 31, 2024 $503.12M
Stockholders Equity Q2 2025 · Jun 30, 2024 $546M
Stockholders Equity Q2 2025 · Mar 31, 2024 $570.32M
Stockholders Equity Q2 2025 · Dec 31, 2023 $598.73M
Current Liabilities Q2 2025 · Jun 30, 2025 $148.38M
Current Liabilities Q2 2025 · Dec 31, 2024 $168.63M
Total Liabilities Q2 2025 · Jun 30, 2025 $378.81M
Total Liabilities Q2 2025 · Dec 31, 2024 $390.17M
Current Assets Q2 2025 · Jun 30, 2025 $395.83M
Current Assets Q2 2025 · Dec 31, 2024 $433.29M
Total Assets Q2 2025 · Jun 30, 2025 $837.16M
Total Assets Q2 2025 · Dec 31, 2024 $893.29M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.36
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.71
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.88
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.84
Eps Basic Q2 2025 · Jun 30, 2025 −$0.36
Eps Basic Q2 2025 · Jun 30, 2025 −$1.71
Eps Basic Q2 2025 · Jun 30, 2024 −$0.88
Eps Basic Q2 2025 · Jun 30, 2024 −$1.84
Sga Expense Q2 2025 · Jun 30, 2025 $136.49M
Sga Expense Q2 2025 · Jun 30, 2025 $269.47M
Sga Expense Q2 2025 · Jun 30, 2024 $134.22M
Sga Expense Q2 2025 · Jun 30, 2024 $265.91M
Rd Expense Q2 2025 · Jun 30, 2025 $15.93M
Rd Expense Q2 2025 · Jun 30, 2025 $35.7M
Rd Expense Q2 2025 · Jun 30, 2024 $18.05M
Rd Expense Q2 2025 · Jun 30, 2024 $37.54M
Net Income Q2 2025 · Jun 30, 2025 −$14.08M
Net Income Q2 2025 · Jun 30, 2025 −$67.18M
Net Income Q2 2025 · Mar 31, 2025 −$53.09M
Net Income Q2 2025 · Jun 30, 2024 −$33.44M
Net Income Q2 2025 · Jun 30, 2024 −$69.46M
Net Income Q2 2025 · Mar 31, 2024 −$36.02M
Operating Income Q2 2025 · Jun 30, 2025 −$16M
Operating Income Q2 2025 · Jun 30, 2025 −$64.88M
Operating Income Q2 2025 · Jun 30, 2024 −$24.91M
Operating Income Q2 2025 · Jun 30, 2024 −$54.24M
Gross Profit Q2 2025 · Jun 30, 2025 $139.53M
Gross Profit Q2 2025 · Jun 30, 2025 $261.15M
Gross Profit Q2 2025 · Jun 30, 2024 $134.75M
Gross Profit Q2 2025 · Jun 30, 2024 $261.99M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $63.59M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $135.62M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $63.87M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $125.24M
Revenue Q2 2025 · Jun 30, 2025 $203.12M
Revenue Q2 2025 · Jun 30, 2025 $396.77M
Revenue Q2 2025 · Jun 30, 2024 $198.62M
Revenue Q2 2025 · Jun 30, 2024 $387.23M